390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials

• Jeffrey Weber,
• Hassane Zarour,
• David Carbone,
• Marcus Butler,
• Roma Patel,
• Melissa Johnson,
• Adrian Sacher,
• Edward Garon,
• Arindam Dhar,
• Cristina Messina,
• Kristin Blouch,
• Axel Hoos,
• Anne-Marie Martin

Affiliations

Jeffrey Weber

24 Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA

Hassane Zarour

Aff13 grid.21925.3d0000000419369000University of Pittsburgh Pittsburgh PA USA

David Carbone

Aff2 grid.152326.10000000122647217Vanderbilt University Nashville TN USA

Marcus Butler

2Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Roma Patel

7GlaxoSmithKline, Collegeville, PA, USA

Melissa Johnson

3Sarah Cannon Research Institute, Nashville, TN, USA

Adrian Sacher

4Princess Margaret Cancer Centre, Toronto, Canada

Edward Garon

David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA

Arindam Dhar

7GlaxoSmithKline, Collegeville, PA, USA

Cristina Messina

7GlaxoSmithKline, Collegeville, PA, USA

Kristin Blouch

7GlaxoSmithKline, Collegeville, PA, USA

Axel Hoos

8GlaxoSmithKline (at the time of publication), Collegeville, PA, USA

Anne-Marie Martin

7GlaxoSmithKline, Collegeville, PA, USA